Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)2.33bn
- Net income in CNY-62.99m
- Incorporated1998
- Employees2.50k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascentage Pharma Group International | 222.59m | -928.16m | 7.89bn | 583.00 | -- | 120.13 | -- | 35.45 | -3.53 | -3.53 | 0.8489 | 0.2248 | 0.0833 | 2.38 | 2.22 | 411,060.30 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
Keymed Biosciences Inc | 355.06m | -360.34m | 7.96bn | 897.00 | -- | 2.66 | -- | 22.43 | -1.49 | -1.49 | 1.45 | 11.52 | 0.0906 | 0.7314 | 26.14 | 426,167.00 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
Bio-Thera Solutions Ltd | 711.46m | -370.90m | 8.26bn | 1.17k | -- | 7.55 | -- | 11.61 | -0.8957 | -0.8957 | 1.72 | 2.64 | 0.3099 | 0.9439 | 6.06 | 609,647.70 | -16.15 | -23.62 | -23.70 | -30.81 | 71.41 | 79.76 | -52.13 | -106.72 | 0.8258 | -367.55 | 0.3515 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
InnoCare Pharma Ltd | 740.55m | -632.99m | 8.64bn | 1.09k | -- | 1.03 | -- | 11.67 | -0.4041 | -0.4041 | 0.4725 | 4.38 | 0.073 | 1.39 | 3.39 | 732,144.50 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Clarity Pharmaceuticals Ltd | 0.00 | -145.13m | 9.07bn | -- | -- | 30.39 | -- | -- | -0.1167 | -0.1167 | 0.00 | 0.2017 | 0.00 | -- | -- | -- | -41.34 | -- | -45.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3.57 | -- | -- | -- |
Joinn Laboratories China Co Ltd | 2.33bn | -62.99m | 9.56bn | 2.50k | -- | 1.30 | -- | 4.10 | -0.0862 | -0.0862 | 3.12 | 10.75 | 0.23 | 0.6906 | 8.14 | -- | -0.6856 | 8.99 | -0.8219 | 11.07 | 39.46 | 46.76 | -2.98 | 32.01 | 3.51 | 0.9996 | 0.0079 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 9.63bn | 1.49k | -- | 4.00 | -- | 50.33 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
Polaris Group LLC | 7.75m | -374.20m | 10.89bn | -- | -- | 6.76 | -- | 1,404.81 | -2.28 | -2.28 | 0.0472 | 9.78 | 0.0038 | -- | 4.58 | -- | -18.71 | -16.55 | -20.12 | -17.96 | -24.76 | -- | -4,904.26 | -12,960.21 | 12.67 | -- | 0.141 | -- | 16.18 | -- | -37.05 | -- | 50.45 | -- |
RemeGen Co Ltd | 1.08bn | -1.52bn | 11.40bn | 3.62k | -- | 2.01 | -- | 10.56 | -3.03 | -3.03 | 2.16 | 6.90 | 0.1864 | 0.4005 | 4.31 | 321,372.60 | -26.17 | -18.66 | -31.75 | -23.75 | 76.48 | 81.94 | -140.43 | -102.88 | 1.31 | -64.32 | 0.2682 | -- | 40.16 | 148.65 | -51.30 | -- | 59.07 | -- |
Data as of Jul 29 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.79%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Harvest Fund Management Co., Ltd.as of 28 Mar 2024 | 16.32m | 2.59% |
Hwabao WP Fund Management Co., Ltd.as of 28 Mar 2024 | 10.71m | 1.70% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 7.78m | 1.23% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.44m | 1.02% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.44m | 0.55% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.77m | 0.44% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.30m | 0.37% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 2.25m | 0.36% |
The Vanguard Group, Inc.as of 04 Jul 2024 | 1.94m | 0.31% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 1.45m | 0.23% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.